EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)Open Access

Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection

Jeffrey S Miller iD, Joshua Rhein, Zachary B Davis, Sarah Cooley, David McKenna, Jodi Anderson, Kevin Escandón iD, Garritt Wieking, Jarrett Reichel, Ann Thorkelson, Siri Jorstad, Jeffrey T Safrit und 4 weitere

The Journal of Infectious Diseases · 2024

DOI: 10.1093/infdis/jiad578 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift The Journal of Infectious Diseases, 2024. Verfasst von Jeffrey S Miller und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, HIV Infections, Interleukin-2, Interleukin-15. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, MHealth, University of Minnesota.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Natural killer (NK) cells are dysfunctional in chronic human immunodeficiency virus (HIV) infection as they are not able to clear virus. We hypothesized that an infusion of NK cells, supported by interleukin 2 (IL-2) or IL-15, could decrease virus-producing cells in the lymphatic tissues.

Methods

We conducted a phase 1 pilot study in 6 persons with HIV (PWH), where a single infusion of haploidentical related donor NK cells was given plus either IL-2 or N-803 (an IL-15 superagonist).

Results

The approach was well tolerated with no unexpected adverse events. We did not pretreat recipients with cyclophosphamide or fludarabine to “make immunologic space,” reasoning that PWH on stable antiretroviral treatment remain T-cell depleted in lymphatic tissues. We found donor cells remained detectable in blood for up to 8 days (similar to what is seen in cancer pretreatment with lymphodepleting chemotherapy) and in the lymph nodes and rectum up to 28 days. There was a moderate decrease in the frequency of viral RNA-positive cells in lymph nodes.

Conclusions

There was a moderate decrease in HIV-producing cells in lymph nodes. Further studies are warranted to determine the impact of healthy NK cells on HIV reservoirs and if restoring NK-cell function could be part of an HIV cure strategy. Clinical Trials Registration. NCT03346499 and NCT03899480.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalHIV InfectionsInterleukin-2Interleukin-15HumansMaleMiddle AgedAdultPilot ProjectsFemaleViral LoadLymph NodesHIV-1

Stichwörter der Autor:innen

HIVIL-15IL-2N-803NK cellsreservoir

Substanzen

Interleukin-2Interleukin-15

Autor:innen und Institutionen

  • Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.
  • Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
  • ImmunityBio, Culver City, California, USA.
  • Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

ORCID-Profile: Jeffrey S Miller, Kevin Escandón, Patrick Soon-Shiong, Timothy W Schacker

Förderung

  • NIH HHS
  • MHealth
  • University of Minnesota
  • NCI NIH HHS
  • Foundation for AIDS Research
  • NCATS NIH HHS
  • National Center for Advancing Translational Sciences
  • National Institutes of Health

Zitieren

APA

Miller, J. S., Rhein, J., Davis, Z. B., Cooley, S., McKenna, D., Anderson, J., Escandón, K., Wieking, G., Reichel, J., Thorkelson, A., Jorstad, S., Safrit, J. T., Soon-Shiong, P., Beilman, G. J., Chipman, J. G., & Schacker, T. W. (2024). Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection. The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiad578

Vancouver

Miller JS, Rhein J, Davis ZB, Cooley S, McKenna D, Anderson J, et al. Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection. The Journal of Infectious Diseases. 2024. doi:10.1093/infdis/jiad578

BibTeX
@article{Miller2024,
  author = {Miller, Jeffrey S and Rhein, Joshua and Davis, Zachary B and Cooley, Sarah and McKenna, David and Anderson, Jodi and Escandón, Kevin and Wieking, Garritt and Reichel, Jarrett and Thorkelson, Ann and Jorstad, Siri and Safrit, Jeffrey T and Soon-Shiong, Patrick and Beilman, Gregory J and Chipman, Jeffrey G and Schacker, Timothy W},
  title = {Safety and Virologic Impact of Haploidentical NK Cells Plus Interleukin 2 or N-803 in HIV Infection},
  journal = {The Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1093/infdis/jiad578}
}
Kostenlos starten →